Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.
about
Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airwaysPharmacotherapy in the management of asthma in the elderly: a review of clinical studiesThe evidence on tiotropium bromide in asthma: from the rationale to the bedside.Novel approaches and targets for treatment of chronic obstructive pulmonary disease.New perspectives in asthma treatment.Novel therapy for COPD.Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease.Anticholinergic bronchodilators in combination.Tiotropium bromide.Asthma, asthma medication and autonomic nervous system dysfunction.Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.Underdiagnosed asthma in South Australia.Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDNew therapies for chronic obstructive pulmonary diseaseEfficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study.Airway responsiveness to psychological processes in asthma and health.Clinical efficacy of tiotropium in children with asthma.Treatment of mild chronic obstructive pulmonary disease.Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: A beneficial off-target effect?Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.Small airways ventilation heterogeneity and hyperinflation in COPD: response to tiotropium bromide.Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor.Comparison of the protective effect amongst anticholinergic drugs on methacholine-induced bronchoconstriction in asthma.Measuring receptor target coverage: a radioligand competition binding protocol for assessing the association and dissociation rates of unlabeled compounds.
P2860
Q24672158-F7A8FF27-8327-4E3E-9554-7B35817D9F68Q26769046-6A3BA514-E515-4903-A274-BDF78BC81A0FQ33644971-753D7120-816E-4758-9D4A-0B8022779772Q33771480-49EBD357-4074-48DF-BBD4-07D244EE2392Q33987222-2D609603-B3A3-46C7-AC14-3F24147A889EQ34074654-6C25248F-1835-480F-B722-973F02E28942Q34177358-C68C8B8A-9552-4DAA-83D0-1B5DEE72CA66Q34181783-6A1898DB-09D6-4005-A7F0-52AD0E8CC2ABQ34204383-57498D02-3F40-4F74-B49A-0342D98C7D0FQ34229318-23E0C5D6-7C3C-4D13-AEFC-D57C20E2BE33Q34243574-D21870E4-1FF8-4CA6-B6C7-7C9D2EB56FF8Q34903093-14385A94-EC6F-4250-AFC3-B87DF783F988Q35535482-897EAE4C-832E-4690-9956-1534E794FE38Q35535487-29C12C25-5663-4C80-93C4-546B4A42AD14Q35535912-A22DF8F6-EB6F-492C-AA31-9F6C7FC0E6B6Q35563923-44B88020-400A-4071-87A6-FA561C86D5C8Q35880368-7B310B77-A565-41A4-A6EC-E1E94399BEC8Q36208336-05AE1690-B3B3-409F-9EA5-F86FDE41A8E6Q36876493-A1E9036F-A3A3-4A0E-8CFE-4B9693EF824BQ37115902-E8EBE2BB-FB57-4654-9AE2-F5FEF8906623Q37667100-E16F64F6-4FB9-448E-8E35-ED943677DAB9Q37672017-5E9B9A9F-C5F2-44E3-9D74-1223BBB5F78CQ37895710-A7BDAED5-C286-428B-A3A3-6329E4D18D8EQ38066977-5037A1B0-F5C7-4B08-A51D-4B0575918958Q41269047-686C6628-49BA-4E5D-811D-12367429DC8BQ42035222-EB2533E0-ECCB-4FB9-95EE-795027A1A790Q46527705-DCA93DF6-FAB5-42D5-8D12-5DC65E9C4927Q51772032-B9C4D0C6-6225-43A7-B744-0C1AFFCB63AB
P2860
Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Tiotropium bromide (Ba 679 BR) ...... f obstructive airways disease.
@ast
Tiotropium bromide (Ba 679 BR) ...... f obstructive airways disease.
@en
Tiotropium bromide (Ba 679 BR) ...... f obstructive airways disease.
@nl
type
label
Tiotropium bromide (Ba 679 BR) ...... f obstructive airways disease.
@ast
Tiotropium bromide (Ba 679 BR) ...... f obstructive airways disease.
@en
Tiotropium bromide (Ba 679 BR) ...... f obstructive airways disease.
@nl
prefLabel
Tiotropium bromide (Ba 679 BR) ...... f obstructive airways disease.
@ast
Tiotropium bromide (Ba 679 BR) ...... f obstructive airways disease.
@en
Tiotropium bromide (Ba 679 BR) ...... f obstructive airways disease.
@nl
P2093
P1433
P1476
Tiotropium bromide (Ba 679 BR) ...... f obstructive airways disease.
@en
P2093
P304
P356
10.1016/0024-3205(95)00020-7
P407
P577
1995-01-01T00:00:00Z